Trafficking and functional defects by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson syndrome

Hepatology

Volumn 36, Issue 5, 2002, Pages 1236-1245

  Hashimoto, Kenkichi ^a   Uchiumi, Takeshi ^a   Konno, Toshikazu ^a   Ebihara, Takuya ^a   Nakamura, Takanori ^a   Wada, Morimasa ^a   Sakisaka, Shotaro ^b   Maniwa, Fumio ^c   Amachi, Teruo ^c   Ueda, Kazumitsu ^c   Kuwano, Michihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 AZIDOADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; ENDOGLYCOSIDASE H; ENZYME PRECURSOR; ESTRADIOL DERIVATIVE; ESTRADIOL GLUCURONIDE; GLUTATHIONE CHLOROBIMANE; GLUTATHIONE ETHYL ESTER; GLYCOSIDASE; LEUKOTRIENE C4; MULTIDRUG RESISTANCE PROTEIN 2; NUCLEOTIDE BINDING PROTEIN; PHOSPHORUS 32; PROTEASOME INHIBITOR; UNCLASSIFIED DRUG; VANADIC ACID;

APICAL MEMBRANE; ARTICLE; CELL MATURATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DUBIN JOHNSON SYNDROME; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME SUBSTRATE COMPLEX; GENE MUTATION; GENETIC DISORDER; HUMAN; HUMAN CELL; HYDROLYSIS; HYPERBILIRUBINEMIA; MISSENSE MUTATION; NUCLEOTIDE TRANSPORT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PULSED FIELD GEL ELECTROPHORESIS; WILD TYPE;

EID: 0036830243     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.36368     Document Type: Article

References (40)

1. Dubin IN, Johnson FB. Chronic idiopathic jaundice with unidentified pigment in liver cells: New clinico-pathologic entity with report of 12 cases. Medicine 1954;33:155-197.
2. Sprinz H, Nelson RS. Persistent nonhemolytic hyperbilirubinemia associated with lipochrome-like pigment in liver cells: Report of 4 cases. Ann Int Med 1954;41:952-962.
3. Shani M, Seligsohn U, Gilon E, Sheba C, Adam A. Dubin-Johnson syndrome in Israel. I. Clinical, laboratory, and genetic aspects of 101 cases. Q J Med 1970;39:549-567.
4. Kondo T, Kazuo K, Ohtsuka Y, Yanagisawa W, Shiomura T. Clinical and genetic studies on Dubin-Johnson syndrome in a cluster area in Japan. Jpn J Hum Genet 1974;18:378-392.
5. Keppler D, Kartenbeck J. The canalicular conjugate export pump encoded by the cmrp/cmoat gene. Prog Liver Dis 1996;14:55-67.
6. Buchler M, Konig J, Brom M, Kartenbeck J, Spring H, Horie T, Keppler D. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol Chem 1996;271:15091-15098.
7. Paulusma CC, Bosma PJ, Zaman GJ, Bakker CT, Otter M, Scheffer GL, Scheper RJ, et al. Congenital jaundice in rats with a mutation in a multi-drug resistance-associated protein gene. Science 1996;271:1126-1128.
8. Ito K, Suzuki H, Hirohashi T, Kume K, Shimizu T, Sugiyama Y. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. Am J Physiol 1997;272:G16-G22.
9. Taniguchi K, Wada M, Kohno K, Nakamura T, Kawabe T, Kawakami M, Kagotani K, et al. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res 1996;56:4124-4129.
10. Kool M, de Haas M, Scheffer GL, Scheper RJ, van Eijk MJ, Juijn JA, Baas F, et al. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res 1997;57:3537-3547.
11. Paulusma CC, Kool M, Bosma PJ, Scheffer GL, ter Borg F, Scheper RJ, Tytgat GN, et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome. Hepatology 1997;25:1539-1542.
12. Wada M, Toh S, Taniguchi K, Nakamura T, Uchiumi T, Kohno K, Yoshida I, et al. Mutations in the canilicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome. Hum Mol Genet 1998;7:203-207.
13. Toh S, Wada M, Uchiumi T, Inokuchi A, Makino Y, Horie Y, Adachi Y, et al. Genomic structure of the canalicular multispecific organic aniontransporter gene (MRP2/cMOAT) and mutations in the ATP-binding cassette region in Dubin-Johnson syndrome. Am J Hum Genet 1999;64:739-746.
14. Hopfner KP, Karcher A, Shin DS, Craig L, Arthur LM, Carney JP, Tainer JA. Structural biology of Rad50 ATPase: ATP-driven conformational control in DNA double-strand break repair and the ABC-ATPase superfamily. Cell 2000;101:789-800.
15. Tsujii H, Konig J, Rost D, Stockel B, Leuschner U, Keppler D. Exonintron organization of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin-Johnson syndrome. Gastroenterology. 1999;117:653-660.
16. Keitel V, Kartenbeck J, Nies AT, Spring H, Brom M, Keppler D. Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome. Hepatology 2000;32:1317-1328.
17. Kajihara S, Hisatomi A, Mizuta T, Hara T, Ozaki I, Wada I, Yamamoto K. A splice mutation in the human canalicular multispecific organic anion transporter gene causes Dubin-Johnson syndrome. Biochem Biophys Res Commun 1998;253:454-457.
18. Mor-Cohen R, Zivelin A, Rosenberg N, Shani M, Muallem S, Seligsohn U. Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome. J Biol Chem 2001;276:36923-36930.
19. Evers R, Kool M, van Deemter L, Janssen H, Calafat J, Oomen LC, Paulusma CC, et al. Drug export activity of the human canalicular multi-specific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. J Clin Invest 1998;101:1310-1319.
20. Kawabe T, Chen ZS, Wada M, Uchiumi T, Ono M, Akiyama S, Kuwano M. Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2). FEBS Lett 1999;456:327-331.
21. Uchiumi T, Longo DL, Ferris DK. Cell cycle regulation of the human polo-like kinase (PLK) promoter. J Biol Chem 1997;272:9166-9174.
22. Chen ZS, Kawabe T, Ono M, Aoki S, Sumizawa T, Furukawa T, Uchiumi T, et al. Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter. Mol Pharmacol 1999;56:1219-1228.
23. Hinoshita E, Uchiumi T, Taguchi K, Kinukawa N, Tsuneyoshi M, Maehara Y, Sugimachi K, et al. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas. Clin Cancer Res 2000;6:2401-2407.
24. Yoshimura A, Yoshida T, Seguchi T, Waki M, Ono M, Kuwano M. Low binding capacity and altered O-linked glycosylation of low density lipoprotein receptor in a monensin-resistant mutant of Chinese hamster ovary cells. J Biol Chem 1987;262:13299-13308.
25. Shite S, Seguchi T, Mizoguchi H, Ono M, Kuwano M. Differential effects of brefeldin A on sialylation of N- and O-linked oligosaccharides in low density lipoprotein receptor and epidermal growth factor receptor. J Biol Chem 1990;265:17385-17388.
26. Seguchi T, Goto Y, Ono M, Fujiwara T, Shimada T, Kung HF, Nishioka M, et al. Brefeldin A-resistant mutants of human epidermoid carcinoma cell line with structural changes of the Golgi apparatus. J Biol Chem 1992;267:11626-11630.
27. Koike K, Kawabe T, Tanaka T, Toh S, Uchiumi T, Wada M, Akiyama S, et al. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells. Cancer Res 1997;57:5475-5479.
28. Koike K, Abe T, Hisano T, Kubo T, Wada M, Kohno K, Kuwano M. Overexpression of multidrug resistance protein gene in human cancer cell lines selected for drug resistance to epipodophyllotoxins. Jpn J Cancer Res 1996;87:765-772.
29. Terlouw SA, Masereeuw R, van den Broek PH, Notenboom S, Russel FG. Role of multidrug resistance protein 2 (MRP2) in glutathione-bimane efflux from Caco-2 and rat renal proximal tubule cells. Br J Pharmacol 2001;134:931-938.
30. Cornwell MM, Gottesman MM, Pastan IH. Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells. J Biol Chem 1986;261:7921-7928.
31. Taguchi Y, Yoshida A, Takada Y, Komano T, Ueda K. Anti-cancer drugs and glutathione stimulate vanadate-induced trapping of nucleotide in muttidrug resistance-associated protein (MRP). FEBS Lett 1997;401:11-14.
32. Roelofsen H, Soroka CJ, Keppler D, Boyer JL. Cyclic AMP stimulates sorting of the canalicular organic anion transporter (Mrp2/cMoat) to the apical domain in hepatocyte couplets. J Cell Sci 1998;111:1137-1145.
33. Gao M, Cui HR, Loe DW, Grant CE, Almquist KC, Cole SP, Deeley RG. Comparison of the functional characteristics of the nucleotide binding domains of multidrug resistance protein 1. J Biol Chem 2000;275:13098-13108.
34. Nagata K, Nishitani M, Matsuo M, Kioka N, Amachi T, Ueda K, Non-equivalent nucleotide trapping in the two nucleotide binding folds of the human multidrug resistance protein MRP1. J Biol Chem 2000;275:17626-17630.
35. van Aubel RA, van Kuijck MA, Koenderink JB, Deen PM, van Os CH, Russel FG. Adenosine triphosphate-dependent transport of anionic conjugates by the rabbit multidrug resistance-associated protein Mrp2 expressed in insect cells. Mol Pharmacol 1998;53:1062-1067.
36. Schwartz AL, Ciechanover A. The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu Rev Med 1999;50:57-74.
37. Jensen TJ, Loo MA, Pind S, Williams DB, Goldberg AL, Riordan JR. Multiple proteolytic systems, including the proreasome, contribute to CFTR processing. Cell 1995;83:129-135.
38. Hung LW, Wang IX, Nikaido K, Liu PQ, Ames GF, Kim SH. Crystal structure of the ATP-binding subunit of an ABC transporter. Nature 1998;396:703-707.
39. Dork T, Mekus F, Schmidt K, Bosshammer J, Fislage R, Heuer T, Dziadek V, et al. Detection of more than 50 different CFTR mutations in a large group of German cystic fibrosis patients. Hum Genet 1994;94:533-542.
40. Diederichs K, Diez J, Greller G, Muller C, Breed J, Schnell C, Vonrhein C, et al. Crystal structure of MalK, the ATPase subunit of the trehalose/maltose ABC transporter of the archaeon Thermococcus litoralis. EMBO J 2000;19:5951-5961.